{"transactions":[{"id":740093,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-06-12T22:01:09.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030."}],"balance_after":80000,"derivative":{"exercise_price":1.08,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-26-073620","document":"tm2617880-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000110465926073620/tm2617880-11_4seq1.xml","form_type":"4"}},{"id":1109875,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-06-16T20:31:56.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029."}],"balance_after":80000,"derivative":{"exercise_price":2.41,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001818382-25-000114","document":"wk-form4_1750105909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000114/wk-form4_1750105909.xml","form_type":"4"}},{"id":1467247,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2024-06-28T20:36:12.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":261000,"derivative":{"exercise_price":0.063,"exercise_date":"2024-06-27","expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-24-025678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000149315224025678/ownership.xml","form_type":"4"}},{"id":1477451,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-06-17T20:12:56.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028."}],"balance_after":50000,"derivative":{"exercise_price":7.2,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001818382-24-000142","document":"wk-form4_1718655168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838224000142/wk-form4_1718655168.xml","form_type":"4"}},{"id":1777387,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-09-19T16:05:26.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the options vest on the date of grant and 1,250 vest on a monthly basis thereafter for six months."}],"balance_after":73500,"derivative":{"exercise_price":0.08,"expiration_date":"2033-09-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-033067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000149315223033067/ownership.xml","form_type":"4"}},{"id":1847875,"issuer":{"id":112047,"kind":"organization","name":"Histogen Inc.","symbol":"HSTO"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-21T16:11:05.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":6835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was issued to the Reporting Person, a non-employee director of the Issuer, for her service as a director of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option become fully vested and exercisable on 6/20/2024, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":6835,"derivative":{"exercise_price":0.828,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":6835},"source":{"system":"sec-edgar","filing":"0001209191-23-038769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000120919123038769/doc4.xml","form_type":"4"}},{"id":1852541,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-16T20:10:10.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027."}],"balance_after":8500,"derivative":{"exercise_price":3.35,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001818382-23-000086","document":"wf-form4_168694619989218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000086/wf-form4_168694619989218.xml","form_type":"4"}},{"id":1854390,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-15T17:12:38.000Z","date":"2023-06-05","kind":"exercise","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"5,000 shares of Common Stock vested on June 5, 2023 and 5,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"5,000 shares of Common Stock vested on June 5, 2023 and 5,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-021478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000149315223021478/ownership.xml","form_type":"4"}},{"id":1854389,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-15T17:12:38.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the options vest on the three month anniversary of the date of grant and the remainder vest on the six month anniversary of the date of grant."}],"balance_after":58500,"derivative":{"exercise_price":0.16,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-021478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000149315223021478/ownership.xml","form_type":"4"}},{"id":1854388,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T17:12:38.000Z","date":"2023-06-05","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001493152-23-021478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000149315223021478/ownership.xml","form_type":"4"}},{"id":2093301,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-07T08:57:19.000Z","date":"2022-12-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"5,000 shares of Common Stock will vest on June 5, 2023 and 5,000 will vest on 12/5/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"5,000 shares of Common Stock will vest on June 5, 2023 and 5,000 will vest on 12/5/2023."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-034674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000149315222034674/ownership.xml","form_type":"4"}},{"id":2234303,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-13T20:22:09.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026."}],"balance_after":8500,"derivative":{"exercise_price":4.34,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001818382-22-000092","document":"wf-form4_165515171376202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000092/wf-form4_165515171376202.xml","form_type":"4"}},{"id":2244875,"issuer":{"id":112047,"kind":"organization","name":"Histogen Inc.","symbol":"HSTO"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T16:41:17.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 and the exercise price have been adjusted to reflect the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was issued to the Reporting Person, a non-employee director of the Issuer, for her service as a director of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option become fully vested and exercisable on 6/1/2023, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":1000,"derivative":{"exercise_price":3.2,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-22-034098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000120919122034098/doc4.xml","form_type":"4"}},{"id":2541757,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-10-15T19:29:35.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025."}],"balance_after":13000,"derivative":{"exercise_price":10.03,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-21-126700","document":"tm2130120-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000110465921126700/tm2130120-11_4seq1.xml","form_type":"4"}},{"id":2549076,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-10-05T19:01:32.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in equal installments over 12 months, beginning on October 4, 2021."}],"balance_after":43500,"derivative":{"exercise_price":3.6,"expiration_date":"2031-10-04","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001104659-21-123305","document":"tm2129291-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000110465921123305/tm2129291-6_4seq1.xml","form_type":"4"}},{"id":2792195,"issuer":{"id":112047,"kind":"organization","name":"Histogen Inc.","symbol":"HSTO"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-12T16:18:32.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in substantially equal installments on each of the first three anniversaries of the grant date, subject to reporting person's continued service as a director on such dates."}],"balance_after":30000,"derivative":{"exercise_price":1.23,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-020150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000120919121020150/doc4.xml","form_type":"4"}},{"id":3426731,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-08-29T11:37:32.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is filing this Amendment to correct the vesting terms for the stock options that were reported in the original form 4. The stock options vest in 36 equal monthly installments beginning on June 5, 2019."}],"balance_after":35000,"derivative":{"exercise_price":10.01,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-19-047878","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000110465919047878/a4a.xml","form_type":"4/A","original_submission_date":"2019-07-15"}},{"id":3461973,"issuer":{"id":89417,"kind":"organization","name":"Aridis Pharmaceuticals, Inc.","symbol":"ARDS"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-15T08:06:09.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"972 of the stock options vested upon date of grant and the remaining stock options vest in equal installments over 35 months beginning on July 12, 2019."}],"balance_after":35000,"derivative":{"exercise_price":10.01,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-19-040253","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1713760/000110465919040253/a4.xml","form_type":"4"}},{"id":3886657,"issuer":{"id":88977,"kind":"organization","name":"CAMBRIDGE BANCORP","symbol":"CATC"},"owners":[{"id":38799,"kind":"person","name":"Windham-Bannister Susan Richards","position":1,"cik":"0001713760","reported_name":"Windham-Bannister Susan Richards","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T14:36:24.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":347,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":347,"source":{"system":"sec-edgar","filing":"0001593968-18-000951","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/711772/000159396818000951/primary_01.xml","form_type":"4"}}]}